Essex Investment Management CO LLC Vericel Corp Transaction History

Essex Investment Management CO LLC

$516 Million
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$35.2 - $52.6 $1.42 Million - $2.13 Million	-40,406 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$46.35 - $59.75 $11,911 - $15,355	-257 Reduced 0.63%	40,406 $1.97 Million
Q2 2021 Aug 12, 2021	SELL	$47.2 - $67.81 $1.56 Million - $2.24 Million	-33,036 Reduced 44.83%	40,663 $2.13 Million
Q1 2021 May 12, 2021	SELL	$30.93 - $59.48 $839,409 - $1.61 Million	-27,139 Reduced 26.91%	73,699 $4.09 Million
Q4 2020 Feb 12, 2021	SELL	$18.53 - $31.5 $342,601 - $582,403	-18,489 Reduced 15.49%	100,838 $3.11 Million
Q3 2020 Nov 12, 2020	BUY	$14.68 - $19.12 $57,413 - $74,778	3,911 Added 3.39%	119,327 $2.21 Million
Q2 2020 Aug 04, 2020	SELL	$8.5 - $15.82 $4,785 - $8,906	-563 Reduced 0.49%	115,416 $1.6 Million
Q1 2020 May 04, 2020	SELL	$7.25 - $19.22 $44,457 - $117,857	-6,132 Reduced 5.02%	115,979 $1.06 Million
Q4 2019 Feb 10, 2020	BUY	$13.77 - $19.2 $79,232 - $110,476	5,754 Added 4.95%	122,111 $2.13 Million
Q3 2019 Oct 22, 2019	SELL	$14.93 - $19.83 $199,390 - $264,829	-13,355 Reduced 10.3%	116,357 $1.76 Million
Q2 2019 Aug 15, 2019	SELL	$15.01 - $18.89 $357,898 - $450,413	-23,844 Reduced 15.53%	129,712 $2.45 Million
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $61,933 - $77,426	-3,816 Reduced 2.42%	153,556 $2.69 Million
Q4 2018 Feb 06, 2019	BUY	$10.77 - $18.44 $32,826 - $56,205	3,048 Added 1.98%	157,372 $2.74 Million
Q3 2018 Oct 16, 2018	BUY	$9.1 - $14.8 $519,628 - $845,109	57,102 Added 58.73%	154,324 $2.18 Million
Q2 2018 Jul 17, 2018	BUY	$9.6 - $14.6 $297 - $452	31 Added 0.03%	97,222 $943,000
Q1 2018 Apr 26, 2018	BUY	$5.7 - $12.3 $553,988 - $1.2 Million	97,191 New	97,191 $967,000

Others Institutions Holding VCEL

# of Institutions

292

Shares Held

49.4M

Call Options Held

98.2K

Put Options Held

135K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.26B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account